Drugs / Tandospirone
Tandospirone
also known as
Metanopirone · Sediel · SM-3997 · SM-3997 CITRATE · Tandospirona · Tandospirone Citrate · TANDOSPIRONE HYDROCHLORIDE
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03667677 | Feb 2019 → Feb 2020 | anxiety, hypertensive disorder | Chongqing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT03151382 | May → Dec 2017 | Alzheimer disease | Zhejiang Provincial People's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02040883 | Feb → Dec 2014 | schizophrenia | Qingyun Yin | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01614041 Comparator | Jan 2012 → Sep 2018 | generalized anxiety disorder | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tandospirone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02040883 ↗ |
| Known as | Metanopirone | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Known as | Sediel | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Known as | SM-3997 | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Known as | SM-3997 CITRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Known as | Tandospirona | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Known as | Tandospirone Citrate | “Drug: Tandospirone Citrate” NCT03151382 ↗ |
| Known as | TANDOSPIRONE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL274047 ↗ |
| Action | Activate | “5-Hydroxytryptamine 1A (5-HT1A) receptor partial agonist tandospirone” NCT02040883 ↗ |
| Modality | Small molecule | — CHEMBL274047 ↗ |
| Route | Oral | “Usual dose treatment of Tandospirone, oral, 30 mg/day” NCT01614041 ↗ |